A new and increasingly widely used diabetes medication may have additional health benefits for older adults, according to new ...

Innogen, a Shanghai-based medical technology company, announced that its independently developed, human-derived, ...

A recent review shows who newer medications for type 2 diabetes may help the most, particularly in reducing the risk of ...

SGLT2 inhibitors more cardioprotective in older versus younger people despite smaller reduction in HbA1c with older age ...

People with diabetes are more prone to developing Staphylococcus aureus, a leading cause of infections and death associated ...

A new study examines how cost, side effects, and other factors influence whether people stop GLP-1s, while Noom cuts staff to ...

The study offers promising news for people with type 2 diabetes. By using SGLT2 inhibitors, they may be able to lower their ...

A recent study from the University of Hong Kong suggests that a newer type of diabetes drug, called sodium-glucose cotransporter 2 inhibitors (SGLT2i), may help protect the kidneys and lungs in people ...

A majority with overweight/obesity discontinue within a year, but the rate is higher among those without type 2 diabetes.

Nearly 2 in 3 people without diabetes quit popular weight loss drugs such as Ozempic or Victoza within one year, according to ...

Health experts are investigating a possible link between popular weight loss drugs like Ozempic and sudden blindness.

New research found that over half of people with type 2 diabetes in the Americas may be deficient in essential nutrients, ...